| Teke Enterprises Inc | |
|
810 W 3rd St, Elk City, OK 73644-5210 | |
| (580) 366-3996 | |
| (580) 225-5386 |
| Full Name | Teke Enterprises Inc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 810 W 3rd St, Elk City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013299296 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| Provider Name | Theodore D Hasty |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1891914925 PECOS PAC ID: 5890960637 Enrollment ID: I20200206000550 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
U.S. District Judge for the District of Columbia Ricardo Urbina on Monday rejected a request for a preliminary injunction against a Medicare competitive bidding program for durable medical equipment, CongressDaily reports (Edney, CongressDaily, 6/30).
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
Scientists have developed a small-molecule-inhibiting drug that in early laboratory cell tests stopped breast cancer cells from spreading and also promoted the growth of early nerve cells called neurites.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Teke Enterprises Inc 810 W 3rd St, Elk City, OK 73644-5210 Ph: (580) 366-3036 | Teke Enterprises Inc 810 W 3rd St, Elk City, OK 73644-5210 Ph: (580) 366-3996 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
U.S. District Judge for the District of Columbia Ricardo Urbina on Monday rejected a request for a preliminary injunction against a Medicare competitive bidding program for durable medical equipment, CongressDaily reports (Edney, CongressDaily, 6/30).
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
Scientists have developed a small-molecule-inhibiting drug that in early laboratory cell tests stopped breast cancer cells from spreading and also promoted the growth of early nerve cells called neurites.
› Verified 6 days ago
Dr. Stephen Tyler Smith, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2103 S Main St Ste N, Elk City, OK 73644 Phone: 580-243-0700 Fax: 580-243-0771 | |
Dr. Rebecca Dawn Smith, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2103 S Main St Ste N, Elk City, OK 73644 Phone: 580-243-0700 Fax: 580-243-0771 | |
The Chiropractic Co. Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1405 S Main St, Elk City, OK 73644 Phone: 580-339-8078 | |
Dr. Shiloah Adam Stover, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 901 N Main St, Elk City, OK 73644 Phone: 508-225-9944 Fax: 580-225-9943 | |
Dr. Bill Lee Fisher, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1009 N Main St, Elk City, OK 73644 Phone: 580-225-2030 Fax: 580-225-0603 | |
Mikayla Robertson, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1405 S Main St, Elk City, OK 73644 Phone: 580-339-8078 |